Brainstorm Cell Therapeutics BCLI

$ 2.26 8.73%

Quarterly report 2024-Q3
added 11-14-2024

Brainstorm Cell Therapeutics Cash and Cash Equivalents 2011-2024 | BCLI

Annual Cash and Cash Equivalents Brainstorm Cell Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.3 M	772 K	18.9 M	37.8 M	536 K	942 K	2.48 M	547 K	428 K	4.25 M	3.5 M	1.32 M	1.92 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
37.8 M	428 K	5.75 M

Quarterly Cash and Cash Equivalents Brainstorm Cell Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
168 K	3.47 M	779 K	1.3 M	1.22 M	546 K	2.02 M	772 K	4.14 M	9 M	15.2 M	18.9 M	25.7 M	30.6 M	35.9 M	37.8 M	37.8 M	37.8 M	37.8 M	536 K	536 K	536 K	536 K	942 K	942 K	942 K	942 K	2.48 M	2.48 M	2.48 M	2.48 M	547 K	547 K	547 K	547 K	428 K	428 K	428 K	428 K	4.25 M	4.25 M	4.25 M	4.25 M	3.5 M	3.5 M	3.5 M	3.5 M	1.32 M	1.32 M	1.32 M	1.32 M	1.92 M	1.92 M	1.92 M	1.92 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
37.8 M	168 K	6.63 M